{"transactions":[{"id":2378783,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, PROD STRAT & COMM PLNG"}}],"security":"Ordinary Shares","published_at":"2022-02-23T18:34:51.000Z","date":"2022-02-18","kind":"tax_withholding","acquired":false,"shares":27299,"price":9.61,"value":262343.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":380123,"source":{"system":"sec-edgar","filing":"0001415889-22-001701","document":"form4-02232022_030237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000141588922001701/form4-02232022_030237.xml","form_type":"4"}},{"id":2406421,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, PROD STRAT & COMM PLNG"}}],"security":"Ordinary Shares","published_at":"2022-02-09T17:03:59.000Z","date":"2022-02-07","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":407422,"source":{"system":"sec-edgar","filing":"0001415889-22-001184","document":"form4-02092022_020249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000141588922001184/form4-02092022_020249.xml","form_type":"4"}},{"id":2498055,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, PROD STRAT & COMM PLNG"}}],"security":"Ordinary Shares","published_at":"2021-11-23T20:24:11.000Z","date":"2021-11-19","kind":"tax_withholding","acquired":false,"shares":4310,"price":8.36,"value":36031.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":355422,"source":{"system":"sec-edgar","filing":"0001415889-21-005469","document":"form4-11232021_051103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000141588921005469/form4-11232021_051103.xml","form_type":"4"}},{"id":2592319,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2021-08-24T18:59:42.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":4307,"price":14.05,"value":60513.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":359732,"source":{"system":"sec-edgar","filing":"0001179110-21-008398","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911021008398/edgar.xml","form_type":"4"}},{"id":2698982,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2021-05-24T18:14:09.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":4310,"price":17.8,"value":76718.0,"ownership":{"direct":true},"balance_after":364039,"source":{"system":"sec-edgar","filing":"0001179110-21-005846","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911021005846/edgar.xml","form_type":"4"}},{"id":2839433,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2021-02-23T18:10:59.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":31931,"price":18.79,"value":599983.49,"ownership":{"direct":true},"balance_after":368349,"source":{"system":"sec-edgar","filing":"0001179110-21-002167","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911021002167/edgar.xml","form_type":"4"}},{"id":2869232,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2021-02-10T17:46:44.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":400280,"source":{"system":"sec-edgar","filing":"0001179110-21-001538","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911021001538/edgar.xml","form_type":"4"}},{"id":2968182,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2020-11-24T18:19:48.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":4807,"price":17.21,"value":82728.47,"ownership":{"direct":true},"balance_after":335280,"source":{"system":"sec-edgar","filing":"0001179110-20-011371","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911020011371/edgar.xml","form_type":"4"}},{"id":3048771,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2020-08-24T18:29:50.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":4804,"price":18.22,"value":87528.88,"ownership":{"direct":true},"balance_after":340087,"source":{"system":"sec-edgar","filing":"0001179110-20-009269","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911020009269/edgar.xml","form_type":"4"}},{"id":3137353,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2020-05-22T18:09:37.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":4807,"price":26.67,"value":128202.69,"ownership":{"direct":true},"balance_after":344891,"source":{"system":"sec-edgar","filing":"0001179110-20-006528","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911020006528/edgar.xml","form_type":"4"}},{"id":3253038,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2020-02-24T19:11:35.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":29136,"price":25.9,"value":754622.4,"ownership":{"direct":true},"balance_after":349698,"source":{"system":"sec-edgar","filing":"0001179110-20-002150","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911020002150/edgar.xml","form_type":"4"}},{"id":3288768,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2020-02-05T19:02:16.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 3, 2020, the performance conditions applicable to 54,000 shares were achieved and such shares will vest on February 20, 2021, subject to the reporting person's continued service."}],"balance_after":378834,"source":{"system":"sec-edgar","filing":"0001179110-20-001204","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911020001204/edgar.xml","form_type":"4"}},{"id":3288767,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2020-02-05T19:02:16.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":324834,"source":{"system":"sec-edgar","filing":"0001179110-20-001204","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911020001204/edgar.xml","form_type":"4"}},{"id":3361228,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2019-11-22T18:23:17.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":2272,"price":17.6,"value":39987.2,"ownership":{"direct":true},"balance_after":259834,"source":{"system":"sec-edgar","filing":"0001179110-19-012017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911019012017/edgar.xml","form_type":"4"}},{"id":3431178,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2019-08-22T18:03:48.000Z","date":"2019-08-20","kind":"tax_withholding","acquired":false,"shares":2272,"price":21.51,"value":48870.72,"ownership":{"direct":true},"balance_after":262106,"source":{"system":"sec-edgar","filing":"0001179110-19-009792","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911019009792/edgar.xml","form_type":"4"}},{"id":3515376,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2019-05-22T18:11:57.000Z","date":"2019-05-20","kind":"tax_withholding","acquired":false,"shares":2272,"price":19.84,"value":45076.48,"ownership":{"direct":true},"balance_after":264378,"source":{"system":"sec-edgar","filing":"0001179110-19-006527","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911019006527/edgar.xml","form_type":"4"}},{"id":3638896,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2019-02-22T18:18:40.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":3674,"price":27,"value":99198.0,"ownership":{"direct":true},"balance_after":266650,"source":{"system":"sec-edgar","filing":"0001179110-19-002424","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911019002424/edgar.xml","form_type":"4"}},{"id":3670441,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2019-02-07T17:47:38.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 5, 2019, the performance conditions applicable to 47,250 shares were achieved and such shares will vest on February 20, 2020, subject to the reporting person's continued service."}],"balance_after":270324,"source":{"system":"sec-edgar","filing":"0001179110-19-001567","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911019001567/edgar.xml","form_type":"4"}},{"id":3670440,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2019-02-07T17:47:38.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":223074,"source":{"system":"sec-edgar","filing":"0001179110-19-001567","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911019001567/edgar.xml","form_type":"4"}},{"id":3754692,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2018-11-21T17:45:46.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":3908,"price":24.79,"value":96879.32,"ownership":{"direct":true},"balance_after":158074,"source":{"system":"sec-edgar","filing":"0001179110-18-013109","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911018013109/edgar.xml","form_type":"4"}},{"id":3836004,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2018-08-22T19:34:21.000Z","date":"2018-08-20","kind":"tax_withholding","acquired":false,"shares":5043,"price":26.95,"value":135908.85,"ownership":{"direct":true},"balance_after":161982,"source":{"system":"sec-edgar","filing":"0001179110-18-010821","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911018010821/edgar.xml","form_type":"4"}},{"id":3922148,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2018-05-22T19:02:32.000Z","date":"2018-05-20","kind":"tax_withholding","acquired":false,"shares":18779,"price":24.31,"value":456517.49,"ownership":{"direct":true},"balance_after":167025,"source":{"system":"sec-edgar","filing":"0001179110-18-007374","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911018007374/edgar.xml","form_type":"4"}},{"id":3930938,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2018-05-16T19:04:35.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018."}],"balance_after":185804,"source":{"system":"sec-edgar","filing":"0001179110-18-006938","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911018006938/edgar.xml","form_type":"4"}},{"id":4040627,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2018-02-22T17:40:36.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":4252,"price":29.09,"value":123690.68,"ownership":{"direct":true},"balance_after":152054,"source":{"system":"sec-edgar","filing":"0001179110-18-002611","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911018002611/edgar.xml","form_type":"4"}},{"id":4058288,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2018-02-14T18:21:48.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":156306,"source":{"system":"sec-edgar","filing":"0001179110-18-002125","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911018002125/edgar.xml","form_type":"4"}},{"id":4152752,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2017-11-22T16:39:21.000Z","date":"2017-11-20","kind":"tax_withholding","acquired":false,"shares":5014,"price":28.58,"value":143300.12,"ownership":{"direct":true},"balance_after":147306,"source":{"system":"sec-edgar","filing":"0001179110-17-014565","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911017014565/edgar.xml","form_type":"4"}},{"id":4227592,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2017-08-22T18:30:07.000Z","date":"2017-08-20","kind":"tax_withholding","acquired":false,"shares":5013,"price":27.4,"value":137356.2,"ownership":{"direct":true},"balance_after":152320,"source":{"system":"sec-edgar","filing":"0001179110-17-011750","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911017011750/edgar.xml","form_type":"4"}},{"id":4308326,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2017-05-23T20:00:39.000Z","date":"2017-05-20","kind":"tax_withholding","acquired":false,"shares":5014,"price":36.83,"value":184665.62,"ownership":{"direct":true},"balance_after":157333,"source":{"system":"sec-edgar","filing":"0001179110-17-007880","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911017007880/edgar.xml","form_type":"4"}},{"id":4431709,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2017-02-22T19:07:27.000Z","date":"2017-02-20","kind":"tax_withholding","acquired":false,"shares":10030,"price":33.78,"value":338813.4,"ownership":{"direct":true},"balance_after":162347,"source":{"system":"sec-edgar","filing":"0001179110-17-002993","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911017002993/edgar.xml","form_type":"4"}},{"id":4461617,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2017-02-08T19:08:54.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":172377,"source":{"system":"sec-edgar","filing":"0001179110-17-002001","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911017002001/edgar.xml","form_type":"4"}},{"id":4545150,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":130096,"kind":"person","name":"PITZER KENNETH R","position":1,"cik":"0001668775","reported_name":"PITZER KENNETH R","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Prod Strat & Comm Plng"}}],"security":"Ordinary Shares","published_at":"2016-11-22T18:04:13.000Z","date":"2016-11-20","kind":"tax_withholding","acquired":false,"shares":1727,"price":31.96,"value":55194.92,"ownership":{"direct":true},"balance_after":163377,"source":{"system":"sec-edgar","filing":"0001179110-16-031979","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1668775/000117911016031979/edgar.xml","form_type":"4"}}]}